Cardiac-Device Implantation and Pneumothorax—A Symptom-Based Approach: Experience from a District General Hospital

Abstract

In patients undergoing cardiac-device implantation, pneumothorax incidence occurs in 1–6%, and is more common in women over 80 years of age with chronic obstructive pulmonary disease (COPD). The aim of this study was to do a service review to identify ways to improve care delivery. Caldicott approval was gained. Those complicated by a pneumothorax were further analysed regarding basic demographics and pleural interventions and outcomes. Continuous variables are presented as mean (range) or median (with interquartile ranges) and categorical variables are presented as percentages where appropriate. A total of 2056 implantation episodes from January 2010 to December 2020 occurred with 70 pneumothoraxes (3.4%), which were all related to pacemaker insertion. The mean age was 68.1 years (17–97), 39 were female, and 31 were male. A total of 36 pneumothoraxes were small and were 34 large according to British Thoracic Society (BTS) criteria. We initially observed 56 patients with minimal or no symptoms (30 were large pneumothoraxes), with five requiring intercostal drainage (ICD). A total of 14 pneumothoraxes were treated with ICD as a first-line treatment: the mean age was 78 years (69–89) and eight patients had COPD. Five pneumothoraxes were large. All had significant symptoms. All pneumothoraxes resolved within six weeks with no associated mortality.

Keywords

• pneumothorax
• permanent pacemaker
• cardiac-device implantation